This HTML5 document contains 67 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1164/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58321665
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2006 im Januar 2006 veröffentlichter wissenschaftlicher Artikel article wetenschappelijk artikel наукова стаття, опублікована у квітні 2006 հոդված
p:P577
wds:Q58321665-68AB9C95-3B6C-408B-9273-167FD6243FBA
wdt:P577
2006-01-19T00:00:00Z
p:P407
wds:Q58321665-96385B00-BDA3-47F0-85CC-F269C9750AEC
wdt:P407
wd:Q1860
p:P2860
wds:Q58321665-77857493-6670-4DF5-B718-2FA4491F1F1B wds:Q58321665-8D9E6961-7B28-45F1-9D01-49FBB37DA58E wds:Q58321665-27C45BF0-FEB9-4571-A506-365905395E7A wds:Q58321665-2B115F9D-171E-4D2D-B275-AA525E4DEAE8 wds:Q58321665-301C7E70-B3D7-469A-BDC4-80CBC06CF9CE
wdt:P2860
wd:Q56485907 wd:Q58321668 wd:Q44440459 wd:Q39483273 wd:Q41725704
p:P2093
wds:Q58321665-0F04D391-1984-493C-AC39-ACA33E38F949 wds:Q58321665-F7BFF950-8FD5-47FB-A4CD-F0F57A56D7C5 wds:Q58321665-EC2C8FDC-B58F-453C-A982-90346CB0BB2E wds:Q58321665-A1FA2C56-9590-4964-805D-4EB1ED658C30 wds:Q58321665-9E1442FD-04F1-4A01-AEA2-7C872FCB2ED0 wds:Q58321665-5BF5714A-6075-4BCB-9AEC-8ECBEE021B8C
wdt:P2093
Timothy R Sterling James Bethel Tuberculosis Epidemiologic Studies Cosortium Paul Weinfurter Lourdes Yun Stefan Goldberg
rdfs:label
The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada
skos:prefLabel
The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada
schema:name
The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada
p:P50
wds:Q58321665-617251EF-6930-455F-B6C4-E75CD87FC9C9
wdt:P50
wd:Q42864243
p:P1476
wds:Q58321665-AECC500E-A3F4-4666-BF99-9EC6D2C5BED1
wdt:P1476
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada
p:P304
wds:Q58321665-F2AE7262-B2F8-4320-AAB7-020EAB7441A9
wdt:P304
927-931
p:P31
wds:Q58321665-B078AACA-E143-4788-8E57-6524D20EB508
wdt:P31
wd:Q13442814
p:P921
wds:Q58321665-E7C3E62C-C9E1-4559-9CCD-49419789A154 wds:Q58321665-C2CB725A-F1B0-4BC5-9529-5A2BFD9C6F72 wds:Q58321665-0DC48D89-1123-4003-94A1-EF7016475B83 wds:Q58321665-384DC298-A77D-4D12-833B-4D80AE489559
wdt:P921
wd:Q30 wd:Q4254929 wd:Q12204 wd:Q16
p:P698
wds:Q58321665-FF28BC2C-A784-4C12-B799-68394EA377ED
wdtn:P698
n11:16424442
wdt:P698
16424442
p:P1433
wds:Q58321665-1F1641F4-E66B-4B22-A407-E7AC6908D8E2
wdt:P1433
wd:Q4744267
p:P433
wds:Q58321665-3A67DE0B-82C0-4EFB-BEC9-71D0988D9E4B
p:P478
wds:Q58321665-1E535057-7F44-4F3B-974C-617DBA7D6C3C
wdt:P433
8
wdt:P478
173
p:P356
wds:Q58321665-11EF39E1-ED08-4A53-A578-F034AA2856BB
wdtn:P356
n10:RCCM.200510-1563OC
wdt:P356
10.1164/RCCM.200510-1563OC